U.S. Sterilization Coverage and Access: Policies, Trends, and Market Implications
Comprehensive overview of sterilization coverage, insurance policies, provider restrictions, and post-Dobbs trends affecting family planning in the U.S.
Comprehensive overview of sterilization coverage, insurance policies, provider restrictions, and post-Dobbs trends affecting family planning in the U.S.
CMS plans a voluntary five-year trial allowing state Medicaid and Medicare Part D plans to cover GLP-1 weight management drugs, including Ozempic and Wegovy, starting in 2026-27 amid pricing and coverage challenges.
Explore Medicaid's role in funding nursing home care, eligibility requirements, risks of coverage loss, and financial pressures facing providers and states amid a rising senior population.
Explore the Medicare cliff phenomenon where older adults lose Medicaid coverage at 65, leading to increased Medicare costs and coverage changes. Understand eligibility, cost differences, and programs to ease the transition.
Anthem Blue Cross and Blue Shield in Ohio and OhioHealth finalize a multi-year network participation agreement ensuring uninterrupted access for members across all plan types, emphasizing value-based care metrics.
Maine faces proposed health insurance rate increases up to 32% in 2026 driven by rising drug costs, limited competition, Medicaid changes, and expiring premium tax credits.
States to apply September for $50B Rural Health Fund amid Medicare cuts; concerns over urban hospitals dual-classified as rural impacting fund allocation.
Medicare faces evolving opportunities and challenges in covering weight loss drugs through legislation like the Treat and Reduce Obesity Act and federal demonstration projects. Drug adherence and cost-effectiveness remain key issues.
A new report details how modest wage increases can push Virginia's direct care workers into benefits cliffs, reducing their net income and threatening workforce stability amid Medicaid and SNAP changes.
Medicaid cuts could reduce U.S. economic output by $183 billion and cost 408,000 jobs by 2034, with severe impacts on rural hospitals and healthcare access.